Company:  SPLUNK INC (SPLK)
Form Type:  S-1/A
Filing Date:  4/18/2012 
CIK:  0001353283 
Address:  250 BRANNAN STREET 
City, State, Zip:  SAN FRANCISCO, California 94107 
Telephone:  415-848-4800 
Fiscal Year:  01/31 
Last Trade
Last Trade: 
$44.88  
Change: 
-0.23 (-0.51%)  
Trade Time: 
May 23  
Market Cap: 
$4.62B
Description of Business
Register for a Free Trial and access this filing in:     
  FORM S-1/A
    PROSPECTUS (Subject to Completion)
    TABLE OF CONTENTS
    PROSPECTUS SUMMARY
    THE OFFERING
    SUMMARY CONSOLIDATED FINANCIAL DATA
    RISK FACTORS
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    DIVIDEND POLICY
    CAPITALIZATION
      STOCKHOLDERS EQUITY
    DILUTION
      BENEFICIAL OWNERS
    SELECTED CONSOLIDATED FINANCIAL DATA
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF
      Operating Expenses
      Liquidity and Capital Resources
      OPTIONS
    BUSINESS
      Competition
      Employees
      Legal Proceedings
    MANAGEMENT
      NAME AND TITLE
      Compensation Committee Interlocks and Insider Participation
    Non-Employee Director Compensation
    EXECUTIVE COMPENSATION
      COMPENSATION TABLE
      Employee Benefit and Stock Plans
    CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
    Policies and Procedures for Related Party Transactions
    PRINCIPAL AND SELLING STOCKHOLDERS
      BENEFICIAL OWNERS
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    SHARES ELIGIBLE FOR FUTURE SALE
    MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S ...
    UNDERWRITERS
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
      NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
    PART II
      Item 13. Other Expenses of Issuance and Distribution.
      Item 14. Indemnification of Directors and Officers.
      Item 15. Recent Sales of Unregistered Securities.
      Item 16. Exhibits and Financial Statement Schedules.
      Item 17. Undertakings.
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 5.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM